$BIIB
BIOGEN INC. Stock $biib

$biib Overview Financials Valuation SEC Filings Company Website

2016 Q2 Form 10-Q Financial Statement

#000087504516000065 Filed on July 21, 2016

Income Statement

Concept	2016 Q2	2015 Q2
Revenue	$2.894B	$2.592B
YoY Change	11.68%	7.02%
Cost Of Revenue	$370.3M	$286.1M
YoY Change	29.43%	-1.98%
Gross Profit	$2.524B	$2.306B
YoY Change	9.47%	8.26%
Gross Profit Margin	87.21%	88.96%
Selling, General & Admin	$492.4M	$491.9M
YoY Change	0.1%	-14.69%
% of Gross Profit	19.51%	21.34%
Research & Development	$473.1M	$490.7M
YoY Change	-3.59%	9.71%
% of Gross Profit	18.74%	21.28%
Depreciation & Amortization	$175.4M	$144.6M
YoY Change	21.3%	-11.88%
% of Gross Profit	6.95%	6.27%
Operating Expenses	$965.5M	$982.6M
YoY Change	-1.74%	-4.03%
Operating Profit	$1.461B	$1.233B
YoY Change	18.44%	24.72%
Interest Expense	$65.90M	$5.800M
YoY Change	1036.21%	-18.31%
% of Operating Profit	4.51%	0.47%
Other Income/Expense, Net	-$58.50M	-$10.90M
YoY Change	436.7%	-324.23%
Pretax Income	$1.402B	$1.222B
YoY Change	14.71%	23.01%
Income Tax	$353.6M	$292.5M
% Of Pretax Income	25.22%	23.93%
Net Earnings	$1.050B	$927.3M
YoY Change	13.21%	29.78%
Net Earnings / Revenue	36.27%	35.78%
Basic Earnings Per Share	$4.79	$3.94
Diluted Earnings Per Share	$4.79	$3.93
COMMON SHARES
Basic Shares Outstanding	219.1M shares	235.3M shares
Diluted Shares Outstanding	219.4M shares	235.7M shares

Balance Sheet

Concept	2016 Q2	2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.797B	$2.369B
YoY Change	60.28%	50.6%
Cash & Equivalents	$1.362B	$1.282B
Short-Term Investments	$2.435B	$1.087B
Other Short-Term Assets	$1.027B	$750.0M
YoY Change	36.98%	116.28%
Inventory	$996.4M	$865.7M
Prepaid Expenses
Receivables	$1.293B	$1.311B
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$7.448B	$5.619B
YoY Change	32.55%	43.16%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.302B	$1.838B
YoY Change	25.26%	4.64%
Goodwill	$3.167B	$2.154B
YoY Change	47.01%	57.85%
Intangibles	$3.968B	$4.295B
YoY Change	-7.62%	1.07%
Long-Term Investments	$4.592B	$2.853B
YoY Change	60.95%	75.89%
Other Assets	$1.153B	$751.6M
YoY Change	53.41%	22.85%
Total Long-Term Assets	$14.07B	$11.14B
YoY Change	26.27%	23.88%
TOTAL ASSETS
Total Short-Term Assets	$7.448B	$5.619B
Total Long-Term Assets	$14.07B	$11.14B
Total Assets	$21.51B	$16.76B
YoY Change	28.38%	29.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$225.9M	$282.7M
YoY Change	-20.09%	25.68%
Accrued Expenses	$903.0M	$823.0M
YoY Change	9.72%	2.75%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$5.000M	$3.000M
YoY Change	66.67%	0.0%
Total Short-Term Liabilities	$2.516B	$2.556B
YoY Change	-1.55%	33.35%
LONG-TERM LIABILITIES
Long-Term Debt	$6.538B	$576.0M
YoY Change	1035.07%	-1.71%
Other Long-Term Liabilities	$951.0M	$915.7M
YoY Change	3.85%	28.8%
Total Long-Term Liabilities	$951.0M	$915.7M
YoY Change	3.85%	28.8%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.516B	$2.556B
Total Long-Term Liabilities	$951.0M	$915.7M
Total Liabilities	$10.11B	$4.186B
YoY Change	141.54%	24.86%
SHAREHOLDERS EQUITY
Retained Earnings	$14.23B	$11.03B
YoY Change	28.96%	46.27%
Common Stock	$100.0K	$129.0K
YoY Change	-22.48%	0.78%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$2.612B	$2.612B
YoY Change	0.0%	26.67%
Treasury Stock Shares
Shareholders Equity	$11.40B	$12.57B
YoY Change
Total Liabilities & Shareholders Equity	$21.51B	$16.76B
YoY Change	28.38%	29.74%

Cashflow Statement

Concept	2016 Q2	2015 Q2
OPERATING ACTIVITIES
Net Income	$1.050B	$927.3M
YoY Change	13.21%	29.78%
Depreciation, Depletion And Amortization	$175.4M	$144.6M
YoY Change	21.3%	-11.88%
Cash From Operating Activities	$998.2M	$1.047B
YoY Change	-4.69%	5.72%
INVESTING ACTIVITIES
Capital Expenditures	-$108.2M	-$129.9M
YoY Change	-16.71%	102.97%
Acquisitions
YoY Change
Other Investing Activities	-$627.9M	-$1.124B
YoY Change	-44.11%	98.46%
Cash From Investing Activities	-$736.1M	-$1.253B
YoY Change	-41.27%	98.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-15.80M	-3.600M
YoY Change	338.89%	-98.88%
NET CHANGE
Cash From Operating Activities	998.2M	1.047B
Cash From Investing Activities	-736.1M	-1.253B
Cash From Financing Activities	-15.80M	-3.600M
Net Change In Cash	246.3M	-209.6M
YoY Change	-217.51%	-650.13%
FREE CASH FLOW
Cash From Operating Activities	$998.2M	$1.047B
Capital Expenditures	-$108.2M	-$129.9M
Free Cash Flow	$1.106B	$1.177B
YoY Change	-6.01%	11.63%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	600000	shares
	biib	Adjustments To Product Revenue Reserves Relating To Sales In Prior Years AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears	6300000	USD
CY2015Q4	biib	Available For Sale Securities Debt Maturities After Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost	185300000	USD
CY2016Q2	biib	Available For Sale Securities Debt Maturities After Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost	221800000	USD
CY2015Q4	biib	Available For Sale Securities Debt Maturities After Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue	184500000	USD
CY2016Q2	biib	Available For Sale Securities Debt Maturities After Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue	221700000	USD
CY2015	biib	Average Maturity Of Marketable Securities AverageMaturityOfMarketableSecurities	P16M
	biib	Average Maturity Of Marketable Securities AverageMaturityOfMarketableSecurities	P13M
CY2015Q2	biib	Collaborationprofitlosssharing Collaborationprofitlosssharing	0	USD
	biib	Collaborationprofitlosssharing Collaborationprofitlosssharing	0	USD
CY2016Q2	biib	Collaborationprofitlosssharing Collaborationprofitlosssharing	-5600000	USD
	biib	Collaborationprofitlosssharing Collaborationprofitlosssharing	-5600000	USD
	biib	Current Provisions To Product Revenue Reserves Relating To Sales In Current Year CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear	1258200000	USD
CY2015Q4	biib	Duefromanti Cd20therapeuticprograms DuefromantiCD20therapeuticprograms	314500000	USD
CY2016Q2	biib	Duefromanti Cd20therapeuticprograms DuefromantiCD20therapeuticprograms	334100000	USD
CY2015Q2	biib	Effective Income Tax Rate Reconciliation Manufacturing Deduction EffectiveIncomeTaxRateReconciliationManufacturingDeduction	-0.021
	biib	Effective Income Tax Rate Reconciliation Manufacturing Deduction EffectiveIncomeTaxRateReconciliationManufacturingDeduction	-0.018
CY2016Q2	biib	Effective Income Tax Rate Reconciliation Manufacturing Deduction EffectiveIncomeTaxRateReconciliationManufacturingDeduction	-0.016
	biib	Effective Income Tax Rate Reconciliation Manufacturing Deduction EffectiveIncomeTaxRateReconciliationManufacturingDeduction	-0.017
CY2015Q2	biib	Employeestockpurchaseplanmaximumshares Employeestockpurchaseplanmaximumshares	6200000	shares
	biib	Interest In Subsidiary InterestInSubsidiary	1.00
CY2015Q4	biib	Inventorynetcurrentandnoncurrent Inventorynetcurrentandnoncurrent	933600000	USD
CY2016Q2	biib	Inventorynetcurrentandnoncurrent Inventorynetcurrentandnoncurrent	1028700000	USD
CY2015Q4	biib	Investment In Biotechnology Companies That Are Determined To Be Unconsolidated Variable Interest Entities InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities	29200000	USD
CY2016Q2	biib	Investment In Biotechnology Companies That Are Determined To Be Unconsolidated Variable Interest Entities InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities	38000000	USD
CY2015Q2	biib	Noncontrollinginterestincreasedecreaseother Noncontrollinginterestincreasedecreaseother	200000	USD
	biib	Noncontrollinginterestincreasedecreaseother Noncontrollinginterestincreasedecreaseother	200000	USD
CY2016Q2	biib	Noncontrollinginterestincreasedecreaseother Noncontrollinginterestincreasedecreaseother	0	USD
	biib	Noncontrollinginterestincreasedecreaseother Noncontrollinginterestincreasedecreaseother	0	USD
CY2015Q4	biib	Overnightreverserepurchaseagreementspercentoftotalassets Overnightreverserepurchaseagreementspercentoftotalassets	0.007
CY2016Q2	biib	Overnightreverserepurchaseagreementspercentoftotalassets Overnightreverserepurchaseagreementspercentoftotalassets	0.003
	biib	Payments Returns Applied Against Product Revenue Reserves Relating To Current Year PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear	816000000	USD
	biib	Payments Returns Applied Against Product Revenue Reserves Relating To Prior Year PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear	446800000	USD
CY2016Q2	biib	Restructuringand Related Cost Expected Cash Payments RestructuringandRelatedCostExpectedCashPayments	120000000	USD
CY2015Q2	biib	Revenuesfromanti Cd20therapeuticprograms RevenuesfromantiCD20therapeuticprograms	337500000	USD
CY2016Q2	biib	Share Based Compensation Expense Included In Costs And Expenses ShareBasedCompensationExpenseIncludedInCostsAndExpenses	45800000	USD
	biib	Share Based Compensation Expense Included In Costs And Expenses ShareBasedCompensationExpenseIncludedInCostsAndExpenses	97000000	USD
	biib	Revenuesfromanti Cd20therapeuticprograms RevenuesfromantiCD20therapeuticprograms	668100000	USD
CY2016Q2	biib	Revenuesfromanti Cd20therapeuticprograms RevenuesfromantiCD20therapeuticprograms	349200000	USD
	biib	Revenuesfromanti Cd20therapeuticprograms RevenuesfromantiCD20therapeuticprograms	678700000	USD
CY2015Q2	biib	Share Based Compensation Expense Included In Costs And Expenses ShareBasedCompensationExpenseIncludedInCostsAndExpenses	46100000	USD
	biib	Share Based Compensation Expense Included In Costs And Expenses ShareBasedCompensationExpenseIncludedInCostsAndExpenses	133700000	USD
	dei	Entity Central Index Key EntityCentralIndexKey	0000875045
CY2015Q4	biib	Unrealized Gain Losses On Foreign Currency Derivatives Net Before Tax UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax	1800000	USD
	dei	Document Period End Date DocumentPeriodEndDate	2016-06-30
	dei	Document Type DocumentType	10-Q
CY2016Q2	biib	Unrealized Gain Losses On Foreign Currency Derivatives Net Before Tax UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax	16400000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
CY2016Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	219120762	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	BIOGEN INC.
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	267400000	USD
CY2016Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	225900000	USD
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1227000000	USD
CY2016Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1293000000	USD
CY2015Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	167900000	USD
CY2016Q2	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	183700000	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1330100000	USD
CY2016Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1471000000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-59500000	USD
CY2015Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-101000000	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-224000000	USD
CY2016Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-282800000	USD
CY2015Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	0	USD
CY2016Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	69100000	USD
CY2015Q2	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	48300000	USD
	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	139300000	USD
CY2016Q2	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	50200000	USD
	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	104500000	USD
CY2015Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	92000000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	187900000	USD
CY2016Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	92900000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	181700000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2015Q4	us-gaap	Assets Assets	19504800000	USD
CY2016Q2	us-gaap	Assets Assets	21514800000	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	6700300000	USD
CY2016Q2	us-gaap	Assets Current AssetsCurrent	7447700000	USD
CY2015Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	4891200000	USD
CY2016Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	5901300000	USD
CY2015Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	4880900000	USD
CY2016Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	5912400000	USD
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	300000	USD
CY2016Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	13200000	USD
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	10600000	USD
CY2016Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2100000	USD
CY2015Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	4891200000	USD
CY2016Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	5901300000	USD
CY2015Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	2120500000	USD
CY2016Q2	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	2434800000	USD
CY2015Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	2583900000	USD
CY2016Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	3245400000	USD
CY2015Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	2575900000	USD
CY2016Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	3255900000	USD
CY2015Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	2122000000	USD
CY2016Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	2434100000	USD
CY2015Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	2120500000	USD
CY2016Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	2434800000	USD
CY2015Q2	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	300000	USD
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	500000	USD
CY2016Q2	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	600000	USD
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	1000000	USD
CY2015Q2	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	500000	USD
	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	800000	USD
CY2016Q2	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	1200000	USD
	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	1600000	USD
CY2015Q4	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	2760400000	USD
CY2016Q2	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	3477600000	USD
CY2015Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	504700000	USD
CY2016Q2	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	556700000	USD
CY2015Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	301300000	USD
CY2016Q2	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	304000000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1204900000	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1282100000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1308000000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1362000000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	101400000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	53900000	USD
CY2015Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	909500000	USD
CY2016Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	874600000	USD
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0005
CY2016Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0005
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	100000	USD
CY2016Q2	us-gaap	Common Stock Value CommonStockValue	100000	USD
CY2015Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	896800000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1708300000	USD
CY2016Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1026300000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1961900000	USD
CY2015Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	2300000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	4500000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1703700000	USD
CY2016Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1400000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	3100000	USD
CY2015Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	894500000	USD
CY2016Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1024900000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1958800000	USD
CY2015Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	286100000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	598600000	USD
CY2016Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	370300000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	683300000	USD
CY2015Q2	us-gaap	Costs And Expenses CostsAndExpenses	1358500000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	2795600000	USD
CY2016Q2	us-gaap	Costs And Expenses CostsAndExpenses	1433700000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	2782100000	USD
CY2015Q4	us-gaap	Debt Current DebtCurrent	4800000	USD
CY2016Q2	us-gaap	Debt Current DebtCurrent	4800000	USD
CY2015Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	6645900000	USD
CY2016Q2	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	7110900000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-90600000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-30200000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	124900000	USD
CY2016Q2	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	105600000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	292500000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	325100000	USD
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.94
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	7.44
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.79
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	9.23
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.93
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	7.42
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.79
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	9.21
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-24200000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	100000	USD
CY2015Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.239
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.247
CY2016Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.252
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.260
CY2015Q2	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350
CY2016Q2	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350
CY2015Q2	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.111
	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.098
CY2016Q2	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.100
	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.090
CY2015Q2	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization	0.011
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization	0.010
CY2016Q2	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization	0.011
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization	0.011
CY2015Q2	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.009
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.007
CY2016Q2	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.006
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.006
CY2015Q2	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.004
	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.003
CY2016Q2	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.003
	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.002
CY2015Q2	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.004
	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.000
CY2016Q2	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.010
	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.010
CY2015Q2	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.007
	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.007
CY2016Q2	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.012
	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.012
CY2015Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	270800000	USD
CY2016Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	228400000	USD
CY2015Q2	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	2200000	USD
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	5600000	USD
CY2016Q2	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	4400000	USD
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	7500000	USD
CY2015Q2	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	12900000	USD
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	39600000	USD
CY2016Q2	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	12700000	USD
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	27900000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	69700000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	9000000	USD
CY2015Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	2200000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-5600000	USD
CY2016Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-10600000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-12900000	USD
CY2015Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	36000000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	274500000	USD
CY2016Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	0	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	0	USD
CY2015Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	0	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	0	USD
CY2016Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	3200000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	3200000	USD
	us-gaap	Fair Value Measurements Changes In Valuation Techniques FairValueMeasurementsChangesInValuationTechniques	0
CY2015Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3561200000	USD
CY2016Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3742700000	USD
CY2016Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	325100000	USD
CY2016Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	181600000	USD
CY2016Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	265000000	USD
CY2016Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	277100000	USD
CY2016Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	282700000	USD
CY2016Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	298200000	USD
CY2015Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1500000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-14500000	USD
CY2016Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	200000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	2300000	USD
CY2015Q2	us-gaap	Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	13600000	USD
	us-gaap	Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	3900000	USD
CY2016Q2	us-gaap	Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	18600000	USD
	us-gaap	Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	16200000	USD
CY2015Q2	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	300000	USD
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-1400000	USD
CY2016Q2	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-2700000	USD
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-1100000	USD
CY2015Q4	us-gaap	Goodwill Goodwill	2663800000	USD
CY2016Q2	us-gaap	Goodwill Goodwill	3167100000	USD
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	515000000	USD
CY2016Q2	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	0	USD
	us-gaap	Goodwill Other Increase Decrease GoodwillOtherIncreaseDecrease	-11700000	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1222200000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	2325100000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1402000000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	2727600000	USD
CY2015Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-4900000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-5700000	USD
CY2016Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
CY2015Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	292500000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	574400000	USD
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	353600000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	710000000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	38900000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	65000000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	102000000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-151700000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-169900000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-162300000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	81300000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	128300000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	66400000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-50100000	USD
CY2015Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	7646300000	USD
CY2016Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	7710300000	USD
CY2015Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4085100000	USD
CY2016Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3967600000	USD
CY2015Q2	us-gaap	Interest Expense InterestExpense	5800000	USD
	us-gaap	Interest Expense InterestExpense	12500000	USD
CY2016Q2	us-gaap	Interest Expense InterestExpense	65900000	USD
	us-gaap	Interest Expense InterestExpense	129200000	USD
CY2015Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	143000000	USD
CY2016Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	139100000	USD
CY2015Q4	us-gaap	Inventory Net InventoryNet	893400000	USD
CY2016Q2	us-gaap	Inventory Net InventoryNet	996400000	USD
CY2015Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	40200000	USD
CY2016Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	32300000	USD
CY2015Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	213000000	USD
CY2016Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	235000000	USD
CY2015Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	577600000	USD
CY2016Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	654600000	USD
CY2015Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	4300000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	7600000	USD
CY2016Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	15400000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	26600000	USD
CY2015Q4	us-gaap	Liabilities Liabilities	10129900000	USD
CY2016Q2	us-gaap	Liabilities Liabilities	10111100000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19504800000	USD
CY2016Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21514800000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2577700000	USD
CY2016Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2516200000	USD
CY2015Q4	us-gaap	Long Term Debt LongTermDebt	6521500000	USD
CY2016Q2	us-gaap	Long Term Debt LongTermDebt	6538300000	USD
	us-gaap	Maximum Remaining Maturity Of Foreign Currency Derivatives1 MaximumRemainingMaturityOfForeignCurrencyDerivatives1	P18M
CY2014Q4	us-gaap	Minority Interest MinorityInterest	5000000	USD
CY2015Q1	us-gaap	Minority Interest MinorityInterest	2700000	USD
CY2015Q2	us-gaap	Minority Interest MinorityInterest	400000	USD
CY2015Q4	us-gaap	Minority Interest MinorityInterest	2100000	USD
CY2016Q1	us-gaap	Minority Interest MinorityInterest	1300000	USD
CY2016Q2	us-gaap	Minority Interest MinorityInterest	-100000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	77200000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	34000000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1756100000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1939300000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1780300000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1959200000	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	927300000	USD
	us-gaap	Net Income Loss NetIncomeLoss	1749800000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	1049800000	USD
	us-gaap	Net Income Loss NetIncomeLoss	2020700000	USD
CY2015Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2500000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-4800000	USD
CY2016Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1400000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-3100000	USD
CY2015Q2	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	0	USD
	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	0	USD
CY2016Q2	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	0	USD
	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	900000	USD
CY2015Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-10900000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-25900000	USD
CY2016Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-58500000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-111300000	USD
CY2015Q4	us-gaap	Notes Payable NotesPayable	6506500000	USD
CY2016Q2	us-gaap	Notes Payable NotesPayable	6524000000	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	1233100000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	2351000000	USD
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	1460500000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	2838900000	USD
CY2015Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	635300000	USD
CY2016Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	613400000	USD
CY2015Q4	us-gaap	Other Assets Current OtherAssetsCurrent	836900000	USD
CY2016Q2	us-gaap	Other Assets Current OtherAssetsCurrent	1027400000	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1107600000	USD
CY2016Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1153000000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-200000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	1100000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	4500000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	7000000	USD
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	33300000	USD
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-54800000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-96200000	USD
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-8900000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	29300000	USD
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-18300000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	63000000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-37800000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-58000000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-48400000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-30500000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-41500000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-23500000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-58800000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-2900000	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-4100000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-700000	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-900000	USD
CY2015Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2096800000	USD
CY2016Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2072700000	USD
CY2015Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	905800000	USD
CY2016Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	951000000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	5800000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-19800000	USD
CY2015Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-8200000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5100000	USD
CY2016Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5500000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-9900000	USD
CY2015Q2	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	55600000	USD
	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	107600000	USD
CY2016Q2	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	79000000	USD
	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	166900000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	10100000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	65900000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	42200000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
	us-gaap	Payments For Restructuring PaymentsForRestructuring	34700000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	2045000000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	3833300000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	198800000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	250000000	USD
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	600000000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	227700000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	263700000	USD
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q4	us-gaap	Prepaid Taxes PrepaidTaxes	550600000	USD
CY2016Q2	us-gaap	Prepaid Taxes PrepaidTaxes	704100000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	34700000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	23900000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	15000000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	1100000	USD
CY2015Q2	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	601900000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	975500000	USD
CY2016Q2	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	1642500000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	2823600000	USD
CY2015Q2	us-gaap	Profit Loss ProfitLoss	924800000	USD
	us-gaap	Profit Loss ProfitLoss	1745000000	USD
CY2016Q2	us-gaap	Profit Loss ProfitLoss	1048400000	USD
	us-gaap	Profit Loss ProfitLoss	2017600000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2187600000	USD
CY2016Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2301800000	USD
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-74800000	USD
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-4000000	USD
CY2015Q2	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	490700000	USD
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	951300000	USD
CY2016Q2	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	473100000	USD
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	910400000	USD
CY2016Q2	us-gaap	Restructuring And Related Cost Expected Cost1 RestructuringAndRelatedCostExpectedCost1	105000000	USD
CY2015Q2	us-gaap	Restructuring Charges RestructuringCharges	0	USD
	us-gaap	Restructuring Charges RestructuringCharges	0	USD
CY2015Q4	us-gaap	Restructuring Charges RestructuringCharges	93400000	USD
CY2016Q2	us-gaap	Restructuring Charges RestructuringCharges	0	USD
	us-gaap	Restructuring Charges RestructuringCharges	9700000	USD
	us-gaap	Restructuring Costs RestructuringCosts	10300000	USD
CY2015Q4	us-gaap	Restructuring Reserve RestructuringReserve	37300000	USD
CY2016Q2	us-gaap	Restructuring Reserve RestructuringReserve	12300000	USD
	us-gaap	Restructuring Reserve Accrual Adjustment1 RestructuringReserveAccrualAdjustment1	-600000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	12208400000	USD
CY2016Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	14229100000	USD
CY2015Q2	us-gaap	Revenues Revenues	2591600000	USD
	us-gaap	Revenues Revenues	5146600000	USD
CY2016Q2	us-gaap	Revenues Revenues	2894200000	USD
	us-gaap	Revenues Revenues	5621000000	USD
CY2015Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	2198600000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	4370900000	USD
CY2016Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	2466000000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	4775400000	USD
CY2015Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	491900000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1052300000	USD
CY2016Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	492400000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	989700000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	93700000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	84100000	USD
CY2015Q2	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	5000000000	USD
CY2016Q2	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	1300000	shares
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	9372800000	USD
CY2016Q2	us-gaap	Stockholders Equity StockholdersEquity	11403800000	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9374900000	USD
CY2016Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	11403700000	USD
	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	2028800000	USD
CY2015Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	208700000	USD
CY2016Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	212800000	USD
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	100000	shares
CY2015Q4	us-gaap	Treasury Stock Value TreasuryStockValue	2611700000	USD
CY2016Q2	us-gaap	Treasury Stock Value TreasuryStockValue	2611700000	USD
CY2015Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	24000000	USD
CY2015Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	662700000	USD
CY2016Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	651800000	USD
CY2015Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	400000	shares
CY2016Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	300000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	300000	shares
CY2015Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	235700000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	235700000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	219400000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	219300000	shares
CY2015Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	235300000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	235100000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	219100000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	219000000	shares
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The preparation of our condensed consolidated financial statements requires us to make estimates, judgments and assumptions that may affect the reported amounts of assets, liabilities, equity, revenues and expenses and related disclosure of contingent assets and liabilities. On an on-going basis we evaluate our estimates, judgments and methodologies. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable, the results of which form the basis for making judgments about the carrying values of assets, liabilities and equity and the amount of revenues and expenses. Actual results may differ from these estimates under different assumptions or conditions.</font></div></div>

Files In Submission

Name	View Source	Status
biib-2016630_tysabri.jpg	Edgar Link	pending
0000875045-16-000065-index-headers.html	Edgar Link	pending
0000875045-16-000065-index.html	Edgar Link	pending
0000875045-16-000065.txt	Edgar Link	pending
0000875045-16-000065-xbrl.zip	Edgar Link	pending
biib-20160630.xml	Edgar Link	completed
biib-20160630.xsd	Edgar Link	pending
biib-20160630_cal.xml	Edgar Link	unprocessable
biib-20160630_def.xml	Edgar Link	unprocessable
biib-20160630_lab.xml	Edgar Link	unprocessable
biib-20160630_pre.xml	Edgar Link	unprocessable
biib-2016630x10q.htm	Edgar Link	pending
biib-2016630xex101.htm	Edgar Link	pending
biib-2016630xex311.htm	Edgar Link	pending
biib-2016630xex312.htm	Edgar Link	pending
biib-2016630xex321.htm	Edgar Link	pending
biib-2016630_alprolix.jpg	Edgar Link	pending
biib-2016630_amortization.jpg	Edgar Link	pending
biib-2016630_anticd20revenue.jpg	Edgar Link	pending
biib-2016630_benepali.jpg	Edgar Link	pending
biib-2016630_cogs.jpg	Edgar Link	pending
biib-2016630_collabloss.jpg	Edgar Link	pending
biib-2016630_eloctate.jpg	Edgar Link	pending
biib-2016630_equityinloss.jpg	Edgar Link	pending
biib-2016630_finhighlights.jpg	Edgar Link	pending
biib-2016630_gainlossfairval.jpg	Edgar Link	pending
biib-2016630_incometaxes.jpg	Edgar Link	pending
biib-2016630_interferon.jpg	Edgar Link	pending
biib-2016630_oie.jpg	Edgar Link	pending
biib-2016630_otherrevenues.jpg	Edgar Link	pending
biib-2016630_randdpiechart15.jpg	Edgar Link	pending
biib-2016630_randdpiechart16.jpg	Edgar Link	pending
biib-2016630_researchanddev.jpg	Edgar Link	pending
biib-2016630_reserves.jpg	Edgar Link	pending
biib-2016630_restructuring.jpg	Edgar Link	pending
biib-2016630_sellgenandadmin.jpg	Edgar Link	pending
biib-2016630_tecfidera.jpg	Edgar Link	pending
biogenlogostandard.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BIIB
BIOGEN INC. Stock $biib

2016 Q2 Form 10-Q Financial Statement

#000087504516000065 Filed on July 21, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BIIB BIOGEN INC. Stock $biib

2016 Q2 Form 10-Q Financial Statement

#000087504516000065 Filed on July 21, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BIIB
BIOGEN INC. Stock $biib